Astera Labs, Inc. $ALAB Shares Sold by Morse Asset Management Inc

Morse Asset Management Inc lowered its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 30.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 19,396 shares of the company’s stock after selling 8,398 shares during the period. Morse Asset Management Inc’s holdings in Astera Labs were worth $3,227,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in ALAB. Assetmark Inc. increased its position in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Hilltop National Bank increased its position in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares in the last quarter. Aventura Private Wealth LLC acquired a new position in Astera Labs in the 4th quarter valued at about $33,000. National Bank of Canada FI increased its position in Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the period. Finally, Wexford Capital LP acquired a new position in Astera Labs in the 3rd quarter valued at about $39,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Down 0.7%

Shares of NASDAQ:ALAB opened at $201.25 on Tuesday. The company has a 50-day moving average price of $139.00 and a 200 day moving average price of $153.00. Astera Labs, Inc. has a 52 week low of $63.40 and a 52 week high of $262.90. The company has a market cap of $34.47 billion, a P/E ratio of 164.96, a PEG ratio of 3.99 and a beta of 3.34.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter in the previous year, the firm posted $0.37 EPS. The firm’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts expect that Astera Labs, Inc. will post 1.48 EPS for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,064,888 shares of company stock worth $150,764,723 in the last three months. 12.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on ALAB. UBS Group began coverage on Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target on the stock. Loop Capital began coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Barclays set a $165.00 price target on Astera Labs in a research report on Thursday, January 15th. Citigroup began coverage on Astera Labs in a research report on Thursday, April 2nd. They issued a “buy” rating and a $200.00 price target on the stock. Finally, Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $199.20.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.